Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix—A Comparative Analysis of Bioartificial Liver Microenvironments

Induced pluripotent stem cells (iPSCs) are new diagnostic and potentially therapeutic tools to model disease and assess the toxicity of pharmaceutical medications. A common limitation of cell lineages derived from iPSCs is a blunted phenotype compared with fully developed, endogenous cells. We examined the influence of novel three‐dimensional bioartificial microenvironments on function and maturation of hepatocyte‐like cells differentiated from iPSCs and grown within an acellular, liver‐derived extracellular matrix (ECM) scaffold. In parallel, we also compared a bioplotted poly‐l‐lactic acid (PLLA) scaffold that allows for cell growth in three dimensions and formation of cell‐cell contacts but is infused with type I collagen (PLLA‐collagen scaffold) alone as a “deconstructed” control scaffold with narrowed biological diversity. iPSC‐derived hepatocytes cultured within both scaffolds remained viable, became polarized, and formed bile canaliculi‐like structures; however, cells grown within ECM scaffolds had significantly higher P450 (CYP2C9, CYP3A4, CYP1A2) mRNA levels and metabolic enzyme activity compared with iPSC hepatocytes grown in either bioplotted PLLA collagen or Matrigel sandwich control culture. Additionally, the rate of albumin synthesis approached the level of primary cryopreserved hepatocytes with lower transcription of fetal‐specific genes, α‐fetoprotein and CYP3A7, compared with either PLLA‐collagen scaffolds or sandwich culture. These studies show that two acellular, three‐dimensional culture systems increase the function of iPSC‐derived hepatocytes. However, scaffolds derived from ECM alone induced further hepatocyte maturation compared with bioplotted PLLA‐collagen scaffolds. This effect is likely mediated by the complex composition of ECM scaffolds in contrast to bioplotted scaffolds, suggesting their utility for in vitro hepatocyte assays or drug discovery.

[1]  Ludovic Vallier,et al.  Maturation of Induced Pluripotent Stem Cell Derived Hepatocytes by 3D-Culture , 2014, PloS one.

[2]  James A. Thomson,et al.  Induced pluripotent stem cells from a spinal muscular atrophy patient , 2009, Nature.

[3]  M. Ott,et al.  Directed differentiation of murine-induced pluripotent stem cells to functional hepatocyte-like cells. , 2011, Journal of hepatology.

[4]  Yunfang Wang,et al.  Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue‐specific biomatrix scaffolds , 2011, Hepatology.

[5]  Adam E Jakus,et al.  Advancing the field of 3D biomaterial printing , 2016, Biomedical materials.

[6]  Ying Meng,et al.  Differentiation and Enrichment of Hepatocyte‐Like Cells from Human Embryonic Stem Cells In Vitro and In Vivo , 2007, Stem cells.

[7]  Xiaolei Yin,et al.  Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells , 2009, Cell Research.

[8]  D. Arnold,et al.  High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report. , 2015, JAMA neurology.

[9]  Alexandra L. Rutz,et al.  A Multimaterial Bioink Method for 3D Printing Tunable, Cell‐Compatible Hydrogels , 2015, Advanced materials.

[10]  L. Benet,et al.  Mouse liver repopulation with hepatocytes generated from human fibroblasts , 2014, Nature.

[11]  Pedro M. Baptista,et al.  The use of whole organ decellularization for the generation of a vascularized liver organoid , 2011, Hepatology.

[12]  Catherine Payne,et al.  Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling , 2008, Proceedings of the National Academy of Sciences.

[13]  Stephen F Badylak,et al.  A whole-organ regenerative medicine approach for liver replacement. , 2011, Tissue engineering. Part C, Methods.

[14]  S. Badylak,et al.  Solubilized liver extracellular matrix maintains primary rat hepatocyte phenotype in-vitro. , 2016, Journal of biomedical materials research. Part A.

[15]  Stephen Dalton,et al.  Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells , 2010, Hepatology.

[16]  Y. Kan,et al.  Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases , 2009, Proceedings of the National Academy of Sciences.

[17]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[18]  J. Itskovitz‐Eldor,et al.  Directed differentiation of human embryonic stem cells into functional hepatic cells , 2007, Hepatology.

[19]  Sangeeta N Bhatia,et al.  Modeling hepatitis C virus infection using human induced pluripotent stem cells , 2012, Proceedings of the National Academy of Sciences.

[20]  Jehyuk Lee,et al.  Generation of functional human hepatic endoderm from human induced pluripotent stem cells , 2009, Hepatology.

[21]  Stephen F Badylak,et al.  An overview of tissue and whole organ decellularization processes. , 2011, Biomaterials.

[22]  S. Duncan,et al.  Design of a Vitronectin-Based Recombinant Protein as a Defined Substrate for Differentiation of Human Pluripotent Stem Cells into Hepatocyte-Like Cells , 2015, PloS one.

[23]  M. D. Davidson,et al.  Enhancing the functional maturity of induced pluripotent stem cell–derived human hepatocytes by controlled presentation of cell–cell interactions in vitro , 2015, Hepatology.

[24]  A. Kajbafzadeh,et al.  Determining the optimal decellularization and sterilization protocol for preparing a tissue scaffold of a human-sized liver tissue. , 2013, Tissue engineering. Part C, Methods.

[25]  Pedro M. Baptista,et al.  Cellular therapy and bioartificial approaches to liver replacement , 2012, Current opinion in organ transplantation.

[26]  Takao Hayakawa,et al.  3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing. , 2013, Biomaterials.

[27]  Yon Hui Kim,et al.  The homeobox gene Hex regulates hepatocyte differentiation from embryonic stem cell–derived endoderm , 2010, Hepatology.

[28]  M. Wang,et al.  Effective cryopreservation and long-term storage of primary human hepatocytes with recovery of viability, differentiation, and replicative potential. , 1995, Cell transplantation.

[29]  Alejandro Soto-Gutiérrez,et al.  Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. , 2009, Gastroenterology.

[30]  A. Viale,et al.  Modeling Pathogenesis and Treatment of Familial Dysautonomia using Patient Specific iPSCs , 2009, Nature.

[31]  Brian S. Clark,et al.  JD induced pluripotent stem cell–derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia , 2012, Hepatology.

[32]  Ludovic Vallier,et al.  Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. , 2010, The Journal of clinical investigation.

[33]  A. Consiglio,et al.  Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells , 2009, Nature.

[34]  A. Schambach,et al.  Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin. , 2011, Human molecular genetics.

[35]  Junichi Kiryu,et al.  Characterization of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cell Sheets Aiming for Clinical Application , 2014, Stem cell reports.

[36]  Ivan Rusyn,et al.  Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity. , 2013, Toxicology and applied pharmacology.